Novel inhibitor-based therapies for thyroid cancer—An update
M Ratajczak, D Gaweł, M Godlewska - International journal of molecular …, 2021 - mdpi.com
Thyroid cancers (TCs) are the most common tumors of the endocrine system and a constant
rise in the number of TC cases has been observed for the past few decades. TCs are one of …
rise in the number of TC cases has been observed for the past few decades. TCs are one of …
Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two …
M Ragazzi, F Torricelli, B Donati, A Ciarrocchi… - Virchows Archiv, 2021 - Springer
Anaplastic carcinoma (AC) is a rare but highly aggressive form of thyroid cancer. It mostly
arises on a background of pre-existing well-differentiated cancer (WDC); however, whether it …
arises on a background of pre-existing well-differentiated cancer (WDC); however, whether it …
Impact of somatic mutations on survival outcomes in patients with anaplastic thyroid carcinoma
PURPOSE Anaplastic thyroid carcinoma (ATC) uniformly present with aggressive disease,
but the mutational landscape of tumors varies. We aimed to determine whether tumor …
but the mutational landscape of tumors varies. We aimed to determine whether tumor …
Radiomic Model for Determining the Value of Elasticity and Grayscale Ultrasound Diagnoses for Predicting BRAFV600E Mutations in Papillary Thyroid Carcinoma
Y Wang, F Xu, EA Agyekum, H **ang, Y Wang… - Frontiers in …, 2022 - frontiersin.org
BRAFV600E is the most common mutated gene in thyroid cancer and is most closely related
to papillary thyroid carcinoma (PTC). We investigated the value of elasticity and grayscale …
to papillary thyroid carcinoma (PTC). We investigated the value of elasticity and grayscale …
Progress in diagnosing and treating thyroid squamous cell carcinoma under the 5th edition of WHO classification
W Ding, X Gao, X Ran - Frontiers in Endocrinology, 2024 - frontiersin.org
Squamous cell carcinoma of the thyroid (SCCT) is a rare thyroid gland malignancy, with only
a few hundred cases reported in the literature, mostly as case reports or small sample …
a few hundred cases reported in the literature, mostly as case reports or small sample …
An overview on prevalence and detection approaches of BRAF V600E mutation in anaplastic thyroid carcinoma: a systematic review and meta-analysis
Background: BRAF V600E mutation is proved critical in the progression and invasion of
thyroid cancer, and as a prognostic biomarker. As anaplastic thyroid cancer (ATC) is a rare …
thyroid cancer, and as a prognostic biomarker. As anaplastic thyroid cancer (ATC) is a rare …
Primary versus secondary anaplastic thyroid carcinoma: perspectives from multi-institutional and population-level data
Primary (or de novo) anaplastic thyroid carcinoma (ATC) is ATC without pre-existing history
of differentiated thyroid carcinoma (DTC) and no co-existing DTC foci at the time of …
of differentiated thyroid carcinoma (DTC) and no co-existing DTC foci at the time of …
Anaplastic thyroid carcinoma
J Yang, JA Barletta - Seminars in Diagnostic Pathology, 2020 - Elsevier
Anaplastic thyroid carcinoma (ATC) is a rare but significant malignancy due to its high
mortality rate. Rendering an accurate diagnosis is crucial given the prognostic implications …
mortality rate. Rendering an accurate diagnosis is crucial given the prognostic implications …
Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma
H Yamazaki, K Sugino, R Katoh, K Matsuzu… - Cancer …, 2023 - Wiley Online Library
The clinical utilities of paclitaxel in anaplastic thyroid carcinoma (ATC) have been reported.
The current study investigated the outcomes in ATC patients treated by paclitaxel as …
The current study investigated the outcomes in ATC patients treated by paclitaxel as …
Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer
J Li, Y Zhang, F Sun, L **ng, X Sun - Frontiers in Endocrinology, 2022 - frontiersin.org
Dedifferentiated thyroid cancer is the major cause of mortality in thyroid cancer and is
difficult to treat. Hence, the essential molecular mechanisms involved in dedifferentiation …
difficult to treat. Hence, the essential molecular mechanisms involved in dedifferentiation …